English
Published: 2014-09-03 10:20:16 CEST
Arcam AB
Company Announcement
Arcam acquires strategic partner DiSanto Technology
The acquisition of DiSanto Technology (DiSanto), a strategic partner to
Arcam
since February 2013, combines Arcam’s leading edge Additive
Manufacturing
technology with DiSanto’s full-service contract manufacturing
services for
orthopedic implants. Through DiSanto Arcam will offer customers,
including
industry-leading orthopedic and spinal implant companies,
manufacturing of
advanced EBM-based implants and other components.
The
combination of Arcam’s EBM technology and DiSanto´s know-how in
orthopedic
implant manufacturing will accelerate the market adoption of
Additive
Manufacturing in the implant industry. DiSanto’s expertise in
implant
engineering and production of finished components is thus expected to
leverage
Arcam’s EBM technology for Additive Manufacturing of orthopedic
implants.

DiSanto is a fully equipped and certified production facility for
the production
of finished orthopedic implants with approximately 100
employees. In the last 12
months DiSanto generated approximately USD 12M in
revenue and an EBIT of USD
0.6M. The total purchase price amounts to USD 15.8M
paid in cash and through the
execution of Arcam stock options issued to the
sellers in February 2013.

The acquired business will become a subsidiary of
Arcam and continue operating
with the existing management team. The acquisition
is expected to have a
positive effect on Arcam’s earnings per share in
2014.

“Through this acquisition Arcam’s offering will cover the entire supply
chain
for our customers: Metal powders through AP&C, acquired earlier this
year, EBM
systems and services through Arcam AB and finished products through
DiSanto. The
acquisition is thus in line with our growth strategy, it
complements our
technology and product portfolio, and it is immediately
accretive. We are very
pleased to welcome the skilled DiSanto team to the Arcam
group”, says Magnus
René, CEO of Arcam.

“With this deal we will be part of the
leading company in 3D-printing in metals.
This will enable us to help customers
in rapidly developing product applications
and to commercially produce products
for them with Arcam’s cost-efficient,
regulatory-cleared Additive Manufacturing
technology. Being part of a larger
group will also help in accelerating growth
to better serve the growing implant
market”,
says Ronald F. Dunn, President of
DiSanto Technology.

Viant Capital LLC acted as Arcam’s advisor in connection
with the acquisition.

About DiSanto Technology, Inc.

DiSanto was founded by
Ottavio DiSanto in 1967 as a general contract
manufacturer. Over the years, the
company has specialized in contract
manufacturing of orthopedic implants and
today the company has a clientele
consisting of major orthopedic device
companies. DiSanto provides its customers
with engineering, development and
production of implants and instruments of
metal and plastic implants and
components. DiSanto is certified to ISO 9001, ISO
13485 and the company is
registered with the FDA as a contract manufacturer. The
company is located in
Shelton, Connecticut, an area with a thriving implant
industry.
www.disanto.com

About Arcam

Arcam offers industrial 3D-printing solutions for
metals. Arcam’s technology,
EBM®, makes possible cost efficient manufacturing
of products with advanced
functionality. Arcam’s market is global with
customers mainly in the orthopedic
and aerospace industries. Arcam is listed on
Nasdaq OMX Stockholm and the Head
Office is located in Mölndal, Sweden. The
Group provides 3D-printing systems
through Arcam AB in Sweden, Metal powders
through AP&C in Canada and Implant
Contract Manufacturing though DiSanto in the
US. The group has about 220
employees.
For further information please
contact:
Magnus René, CEO Arcam AB
Tel: 0046 31 710 32 00, alt. cell: 0046 702
79 89 99, or e-mail:
magnus.rene@arcam.com
Arcam provides a cost-efficient
Additive Manufacturing solution for production
of metal components. The
technology offers freedom in design combined with
excellent material properties
and high productivity. Arcam’s market is global
with customers mainly in the
orthopedic and aerospace industries. The company
was founded in 1997 and is
listed on NASDAQ OMX Stockholm, Sweden. Head office
and production facilities
are located in Mölndal, Sweden. Support offices are
located in the US, UK,
Italy and
     China.

________________________________________________________________________
     _________
_______

Arcam
AB • Krokslätts Fabriker 27A • SE-431 37 Mölndal, Sweden • 46-31-710 32 00
•
www.arcam.com

 


09035647.pdf